FdaApplication
ANDA 208336
Identifiers
- fda_app_no: ANDA208336
Properties
| Property | Value |
|---|---|
| applicant_name | SUNSHINE LAKE PHARMA CO LTD |
| application_type | ANDA |
| approval_date | 2021-08-30 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET;ORAL |
| LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;1GM | TABLET;ORAL |
| LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;850MG | TABLET;ORAL |
3 products